0
Tobacco Cessation and Prevention: Tobacco Cessation and Prevention Slide |

Cost-Effectiveness of Universally Funding Smoking Cessation Pharmacotherapy

Daniel Altman, MD; Fiona Clement, PhD; Lianne Barnieh, PhD; Braden Manns, MD; Erika Penz, MD
Author and Funding Information

University of Saskatchewan, Saskatoon, SK, Canada


Copyright 2016, American College of Chest Physicians. All Rights Reserved.


Chest. 2016;150(4_S):1303A. doi:10.1016/j.chest.2016.08.1418
Text Size: A A A
Published online

Extract

SESSION TITLE: Tobacco Cessation and Prevention Slide

SESSION TYPE: Original Investigation Slide

PRESENTED ON: Sunday, October 23, 2016 at 07:30 AM - 08:30 AM

PURPOSE: Tobacco use is the leading cause of preventable death in Canada and worldwide. Funding smoking cessation pharmacotherapy increases the likelihood of smoking cessation pharmacotherapy use, number of quit attempts, and the probability of abstinence from smoking. Despite this, most provinces do not universally fund smoking cessation pharmacotherapy. The aim of our study was to model the cost-effectiveness of a health policy of universally funding smoking cessation pharmacotherapy for all Canadian smokers at no cost to the patient.

First Page Preview

View Large
First page PDF preview

Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Figures

Tables

References

NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Some tools below are only available to our subscribers or users with an online account.

Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Related Content

Customize your page view by dragging & repositioning the boxes below.

Find Similar Articles
CHEST Journal Articles
PubMed Articles
Guidelines
NIH State-of-the-Science Conference Statement on tobacco use: prevention, cessation, and control.
National Institutes of Health (NIH) State-of-the-Science Panel | 3/20/2009
Guidelines on bladder cancer: muscle-invasive and metastatic.
European Association of Urology | 10/24/2008
  • CHEST Journal
    Print ISSN: 0012-3692
    Online ISSN: 1931-3543